Literature DB >> 5879496

Conversion of 20-alpha-hydroxycholest-4-en-3-one to progesterone by an adrenal enzyme preparation.

K Shimizu.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1965        PMID： 5879496     DOI： 10.1016/0304-4165(65)90076-0

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN： 0006-3002


× No keyword cloud information.
  5 in total

1.  Association between physical activity and subsequent cardiovascular disease among 5-year breast cancer survivors.

Authors:  Kyae Hyung Kim; Seulggie Choi; Kyuwoong Kim; Jooyoung Chang; Sung Min Kim; Seong Rae Kim; Yoosun Cho; Yun Hwan Oh; Gyeongsil Lee; Joung Sik Son; Sang Min Park
Journal:  Breast Cancer Res Treat       Date:  2021-02-18       Impact factor: 4.872

Review 2.  Epidemiology and genomics of prostate cancer in Asian men.

Authors:  Yao Zhu; Miao Mo; Yu Wei; Junlong Wu; Jian Pan; Stephen J Freedland; Ying Zheng; Dingwei Ye
Journal:  Nat Rev Urol       Date:  2021-03-10       Impact factor: 14.432

3.  Associations between alcohol consumption and cardiovascular disease among long-term survivors of colorectal cancer: a population-based, retrospective cohort study.

Authors:  Gyeongsil Lee; Seogsong Jeong; Seulggie Choi; Kyae Hyung Kim; Jooyoung Chang; Seong Rae Kim; Kyuwoong Kim; Joung Sik Son; Sung Min Kim; Daein Choi; Sang Min Park
Journal:  BMC Cancer       Date:  2021-06-16       Impact factor: 4.430

4.  Insulin-like growth factor 1-induced enolase 2 deacetylation by HDAC3 promotes metastasis of pancreatic cancer.

Authors:  Yan Zheng; Chao Wu; Jimeng Yang; Yue Zhao; Huliang Jia; Min Xue; Da Xu; Feng Yang; Deliang Fu; Chaoqun Wang; Beiyuan Hu; Ze Zhang; Tianen Li; Shican Yan; Xuan Wang; Peter J Nelson; Christiane Bruns; Lunxiu Qin; Qiongzhu Dong
Journal:  Signal Transduct Target Ther       Date:  2020-05-13

Review 5.  Overview of Current Drug Delivery Methods Across the Blood-Brain Barrier for the Treatment of Primary Brain Tumors.

Authors:  Rianne Haumann; Jessica Carvalho Videira; Gertjan J L Kaspers; Dannis G van Vuurden; Esther Hulleman
Journal:  CNS Drugs       Date:  2020-09-23       Impact factor: 5.749
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.